Loncar China BioPharma ETF (CHNA) |
| 13.53 -0.01 (-0.07%) 10-17 15:51 |
| Open: | 14.3 |
| High: | 14.3 |
| Low: | 13.53 |
| Volume: | 9 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 22.89 |
| 52w Low: | 9.76966 |
The fund's advisor endeavors to allocate nearly all of its assets to the specific securities and depositary receipts comprising its benchmark index. This index is crafted to reflect the performance of a modified equal-weighted collection of Chinese companies, each playing a direct role in the expansion of China's pharmaceutical and biotechnology sectors.
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Thu, 24 Apr 2025
CHNA Stock Price, News & Analysis | Loncar China BioPharma ETF - Stock Titan
Wed, 17 Apr 2024
ETFs With The Highest & Lowest Trading Spreads - ETF.com
Fri, 27 Oct 2023
This Week in ETFs: Four New Single-Stock Funds Debut - ETF Database
Wed, 26 Feb 2020
ETF Stocks List: Popular ETFs for Trading & Investing (2026) - Bullish Bears
Wed, 05 Jun 2019
Cancer-Fighting Stocks & ETF: What You Need to Know - Yahoo Finance
Fri, 10 Aug 2018
Chinese biotech and pharmaceuticals ETF - ETF Stream
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
